NIR‐II Perylene Monoimide‐Based Photothermal Agent with Strengthened Donor–Acceptor Conjugation for Deep Orthotopic Glioblastoma Phototheranostics

Abstract

AbstractExtensive efforts have been devoted to the design of organic photothermal agents (PTAs) that absorb in the second near‐infrared (NIR‐II) bio‐window, which can provide deeper tissue penetration that is significant for phototheranostics of lethal brain tumors. Herein, the first example of NIR‐II‐absorbing small organic molecule (N1) derived from perylene monoamide (PMI) and its bio‐application after nano‐encapsulation of N1 to function as a nano‐agent for phototheranostics of deep orthotopic glioblastoma (GBM) is reported. By adopting a dual modification strategy of introducing a donor‐acceptor unit and extending π‐conjugation, the obtained N1 can absorb in 1000–1400 nm region and exhibit high photothermal conversation due to the apparent intramolecular charge transfer (ICT). A choline analogue, 2‐methacryloyloxyethyl phosphorylcholine, capable of interacting specifically with receptors on the surface of the blood‐brain barrier (BBB), is used to fabricate the amphiphilic copolymer for the nano‐encapsulation of N1. The obtained nanoparticles demonstrate efficient BBB‐crossing due to the receptor‐mediated transcytosis as well as the small nanoparticle size of approximately 26 nm. The prepared nanoparticles exhibit excellent photoacoustic imaging and significant growth inhibition of deep orthotopic GBM. The current study demonstrates the enormous potential of PMI‐based NIR‐II PTAs and provides an efficient phototheranostic paradigm for deep orthotopic GBM.